• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism

tetano

Editor, Senior Moderator
Vaccine. 2014 Jul 18. pii: S0264-410X(14)00933-5. doi: 10.1016/j.vaccine.2014.07.007. [Epub ahead of print]
Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism.
Veljkovic V1, Glisic S2, Veljkovic N2, Bojic T3, Dietrich U4, Perovic VR2, Colombatti A5.
Author information
Abstract

Despite plausible evidence for beneficial effects of the vaccination against influenza in cardiovascular diseases (CVD) very limited studies have been carried out to explain the molecular mechanism of this phenomenon. Using the informational spectrum method (ISM), a virtual spectroscopy method for analysis of protein-protein interactions, the bradykinin 2 receptor (BKB2R) was identified as a principal host protein which could mediate molecular processes underlying the cardioprotective effect of influenza vaccines. Based on this finding we suggest that some antibodies elicited by influenza vaccines act as agonists, which activate a BKB2R-associated signaling pathway contributing to the protection against CVD. The ISM analysis of 14 influenza viruses, which were used as components of seasonal vaccines, revealed four vaccine viruses A/Beijing/262/95(H1N1), A/NewCaledonia/20/1999(H1N1), A/Christchurch/28/2003(H3N2) and A/Perth/16/2009(H3N2), which could be suited best for further studies on the cardioprotective effect of influenza vaccines.

Copyright ? 2014. Published by Elsevier Ltd.
KEYWORDS:

Bradykinin 2 receptor; Cardio-vascular diseases; Hemagglutinin; Influenza vaccine; Protein?protein interaction

PMID:
25045818
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25045818
 
Back
Top Bottom